Skip to main content

Federal: HR89

Prescription Freedom Act of 2025

Topics

Over­medicalization

Bill Information

MAHA Approved

Summary

Bill Summary

US HR 89, the Prescription Freedom Act of 2025, would repeal the FDA's authority to mandate prescription requirements for drugs by eliminating subsection (b) of section 503 of the Federal Food, Drug, and Cosmetic Act. The bill would transfer regulatory control over drug dispensing from the federal level to individual states, allowing each state to determine its own prescription requirements based on state law. An exception preserves federal prescription authority only for drugs intended to terminate pregnancies. The repeal would take effect a specified number of months after enactment, fundamentally shifting how Americans access medications.


Why It Matters to MAHA

MAHA strongly supports this bill because it embodies core principles of health freedom and patient autonomy by removing federal barriers to medication access. The current FDA prescription mandate restricts patients' ability to obtain treatments they may need without doctor approval, limiting choice and creating unnecessary bureaucratic obstacles. By devolving authority to states, the bill respects federalism and allows communities to craft drug access policies tailored to their populations' needs and values. This aligns with MAHA's commitment to reducing regulatory paternalism and trusting individuals and states rather than distant federal agencies to make healthcare decisions. Expanding access to medications enhances patient choice and supports innovation in how treatments reach those who need them.

Sponsor

Andy Biggs

Republican Representative (US)

Activity

01/03/2025

Referred to the House Committee on Energy and Commerce.

01/03/2025

Introduced in House

Questions or suggestions?

Have questions about this bill or our legislative tracker? We'd love to hear from you. Contact us and we'll get back to you as soon as possible.